C12Y 103/01022
3-oxo-5alpha-steroid 4-dehydrogenase , i.e. cortisone alpha-reductase
Official title: 3-Oxo-5alpha-steroid 4-dehydrogenase (NADP+) (1.3.1.22), i.e. cortisone alpha-reductase
C12Y103/01022 (3-oxo-5alpha-steroid 4-dehydrogenase , i.e. cortisone alpha-reductase) appears on 13 US grants and 55 published applications in this corpus.
Search patents in C12Y- Granted patents
- 13
- Published applications
- 55
- Assignees
- 11
- Inventors
- 45
- Latest grant
- 14 Sep 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 1 | 1 |
| 2005 | 0 | 36 |
| 2006 | 0 | 1 |
| 2007 | 0 | 3 |
| 2008 | 0 | 3 |
| 2009 | 1 | 5 |
| 2010 | 3 | 1 |
| 2011 | 3 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 1 | 1 |
| 2019 | 1 | 1 |
| 2020 | 0 | 0 |
| 2021 | 1 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 2 |
By publication year. Applications have been published since 2001.
Recent patents
- Asymmetric siRNA for inhibiting expression of male pattern hair loss target gene14 Sep 2021US 11,118,184 B2OliX Pharmaceuticals, Inc.
- Antibody against alopecia-inducing substance as antigen, composition and production method2 Apr 2019US 10,246,520 B2Ostrich Pharma KK
- Antibody against alopecia-inducing substance as antigen, composition and production method22 May 2018US 9,975,964 B2Ostrich Pharma KK
- RNA interference mediated inhibition of Stearoyl-CoA desaturase (SCD) gene expression using short interfering nucelic acid (siNA)13 Sep 2011US 8,017,761 B2Merck Sharp & Dohme Corp.
- RNA interference mediated treatment of alzheimer's disease using short interfering nucleic acid (siNA)13 Sep 2011US 8,017,765 B2Merck Sharp & Dohme Corp.
- Composition for producing bile acids3 Oct 2024US 2024/0325458 A1Jsr Corporation
- Compositions and methods for providing secondary bile acids to a subject8 Aug 2024US 2024/0263251 A1Finch Therapeutics Holdings LLC
- Asymmetric sirna for inhibiting expression of male pattern hair loss target gene19 Dec 2019US 2019/0382771 A1OliX Pharmaceuticals, Inc.
- Antibody against alopecia-inducing substance as antigen, composition and production method23 Aug 2018US 2018/0237539 A1Ostrich Pharma KK
- Antibody against alopecia-inducing substance as antigen, composition and production method13 Oct 2016US 2016/0297894 A1Ostrich Pharma KK
Most cited
By later US patents
- Conjugates and compositions for cellular delivery194US 7,491,805 B2Sirna Therapeutics, Inc. · 2009
- Conjugates and compositions for cellular delivery41US 7,964,578 B2Sirna Therapeutics, Inc. · 2011
- Steroid 5a reductase nucleic acid segments and recombinant vectors and host cells18US 5,422,262 ABoard of Regents, The University of Texas System · 1995
- Method for promoting hair growth17US 6,733,776 B1AntiCancer, Inc. · 2004
- RNA interference mediated inhibition of hypoxia inducible factor 1 (HIF1) gene expression using short interfering nucleic acid (siNA)11US 7,795,422 B2Sirna Therapeutics, Inc. · 2010